Open original FDA record ↗Recall record
- FDA identifier
- Z-1322-2018
- Company in FDA record
- Clinical Diagnostic Systems
- FDA classification date
- Apr 10, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
VITROS TSH reagent lots have been found to generate higher than expected Calibrator level 2 signals on some customer systems. These Calibrator Level 2 responses cause a higher than expected frequency of customer generated calibration curves to fall outside of the calibration quality parameter measuring the gradient of the Customer Calibration Curve between Calibrator Level 2 and Calibrator Level 3.
Source facts
- Action
- Distributors instructed to disgard remaining inventory, complete Confirmation of Receipt form, and firm promised to replace product. Distributors instructed to send letter to customers.
- Initiated
- 2018-01-11
- Root cause
- Nonconforming Material/Component
- Terminated
- 2020-09-08
- Distribution
- Distributors were notified via letter. Lot 5430 was not distributed in the US. Lot 5178 was also affected by this issue, but this lot expired on 31-Mar-2017 so Ortho took no action on this lot.
- Recall number
- Z-1322-2018
- Recall status
- Terminated
- CDRH record ID
- 162526
- FDA classified
- 2018-04-10
- Recall event number
- 79508